Abstract:The adsorption of biomolecules to the surface of nanoparticles (NPs) following administration into biological environments is widely recognized. In particular, the "protein corona" is well understood in terms of formation kinetics and impact upon the biological interactions of NPs. Its presence is an essential consideration in the design of therapeutic NPs. In the present study, the protein coronas of six polymeric nanoparticles of prospective therapeutic use were investigated. These included three colloidal NPs-soft core-multishell (CMS) NPs, plus solid cationic Eudragit RS (EGRS), and anionic ethyl cellulose (EC) nanoparticles-and three nanogels (NGs)-thermoresponsive dendritic-polyglycerol (dPG) nanogels (NGs) and two amino-functionalized dPG-NGs. Following incubation with human plasma, protein coronas were characterized and their biological interactions compared with pristine NPs. All NPs demonstrated protein adsorption and increased hydrodynamic diameters, although the solid EGRS and EC NPs bound notably more protein than the other tested particles. Shifts toward moderately negative surface charges were also observed for all corona bearing NPs, despite varied zeta potentials in their pristine states. While the uptake and cellular adhesion of the colloidal NPs in primary human keratinocytes and human umbilical vein endothelial cells were significantly decreased when bearing the protein corona, no obvious impact was seen in the NGs. By contrast, corona bearing NGs induced marked increases in cytokine release from primary human macrophages not seen with corona bearing colloidal NPs. Despite this, no apparent enhancement to in vitro toxicity was noted. Finally, drug release from EGRS and EC NPs was assessed, where a decrease was seen in the EGRS NPs alone. Together these results provide a direct comparison of the physical and biological impact the protein corona has on NPs of widely varied character and in particular highlights a distinction between the corona's effects on NGs and colloidal NPs.

Protein corona potentiates recovery of nanoparticle-induced disrupted tight junctions in endothelial cells

Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

Towards understanding of nanoparticle–protein corona

Protein Coronas Derived from Cerebrospinal Fluid Enhance the Interactions Between Nanoparticles and Brain Cells

The protein corona and its effects on nanoparticle-based drug delivery systems

Biological Effects of Formation of Protein Corona Onto Nanoparticles

Protein corona, influence on drug delivery system and its improvement strategy: A review

Serum-derived Protein Coronas Affect Nanoparticle Interactions with Brain Cells

A health concern regarding the protein corona, aggregation and disaggregation

Nanoparticle protein corona: from structure and function to therapeutic targeting

The Impact of Protein Corona on the Behavior and Targeting Capability of Nanoparticle-Based Delivery System.

The Yin and Yang of the protein corona on the delivery journey of nanoparticles

Protein Corona: Challenges and Opportunities for Targeted Delivery of Nanomedicines

Combinatory Interpretation of Protein Corona and Shear Stress for Active Cancer Targeting of Bioorthogonally Clickable Gelatin-Oleic Nanoparticles.

The impact of protein corona on the biological behavior of targeting nanomedicines

Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties

A Review for Uncovering the "Protein-Nanoparticle Alliance": Implications of the Protein Corona for Biomedical Applications

The Potential of Protein-Nanomaterial Interaction for Advanced Drug Delivery.

Emerging Well-Tailored Nanoparticulate Delivery System Based on in Situ Regulation of the Protein Corona

An Overview of Nanoparticle Protein Corona Literature

Unveiling the challenges of engineered protein corona from the proteins' perspective